Essential Amino Acids and High Intensity Interval Training
Metabolic Effects of Essential Amino Acids and High-intensity Interval Training
1 other identifier
interventional
84
1 country
1
Brief Summary
Purpose: The primary purpose is to determine the combined effects of essential amino acids (EAA) supplementation and high intensity interval training (HIIT) on body composition, muscle characteristics, and muscle architecture in overweight men and women over the course of eight weeks. A secondary purpose is to determine the metabolic effects of EAA supplementation and HIIT on whole body protein turnover, metabolic rate, substrate metabolism, and metabolomics. A tertiary purpose is to evaluate the modulatory effects of sex on body composition, metabolism, metabolic profile, cardiorespiratory fitness, and hunger and satiety in response to EAA supplementation and HIIT. Participants: Healthy overweight and obese men and women (30-50 years) Procedures (methods): In a block randomized design, 78 healthy, overweight or obese men and women will be randomized, to one of four, eight-week intervention groups using a 2:2:2:1 group allocation design: 1) essential amino acids (EAA) supplementation (7.2 grams EAA daily); 2) HIIT, two days per week of cycle ergometry training; 3) EAA + HIIT; or 4) control (CON), receiving no intervention. Measurements of body composition, muscle characteristics, resting metabolic rate, substrate metabolism, and cardiorespiratory fitness will be measured at baseline, 4-weeks, and 8-weeks. Metabolomics and whole body protein turnover will also be measured at baseline and 8-weeks. Subjects will be asked to arrive to testing sessions following a 12 hour fast (except for water), consuming no food, caffeine, or alcohol. Participants will also be asked to abstain from physical activity for 24 hours prior to testing. Subjects will complete one electronic contact (phone/email screening) and up to 22 in-person sessions (enrollment; 5 testing sessions \[2 at base, 1 at 4week, 2 at 8week\]; 16 training sessions \[for HIIT and EAA+HIIT\]) over the course of 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 26, 2019
CompletedFirst Posted
Study publicly available on registry
September 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2020
CompletedApril 30, 2020
April 1, 2020
10 months
August 26, 2019
April 29, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Fat Free Mass (kg)
Determined from a multi-compartment model
8 weeks
Fat mass (kg)
Determined from a multi-compartment model
8 weeks
Secondary Outcomes (2)
Muscle cross sectional area (cm3)
8 weeks
Echo intensity (a.u.)
8 weeks
Other Outcomes (1)
Metabolic rate (kcal/day)
8 weeks
Study Arms (4)
High intensity interval training (HIIT)
EXPERIMENTALEssential Amino Acid Supplement
EXPERIMENTALHigh intensity interval training + Essential Amino Acid
EXPERIMENTALControl
NO INTERVENTIONInterventions
Oral ingestion of a powdered dietary supplement
Exercise and dietary supplement
Eligibility Criteria
You may qualify if:
- Men and women (25-50 years).
- Overweight and obese: body mass index (BMI) of 27 - 40 kg·m-2 and/or percent body fat \> 25% for men, and BMI of 25 - 40 kg·m-2 and/or Percent Body Fat \> 30% for women.
- Healthy, non-smokers.
- Women: eumenorrheic, reporting consistent menstruation, having 3 regular cycles in the 3 months prior to enrollment, and not pregnant or planning on becoming pregnant.
You may not qualify if:
- Have current and/or history of cardiovascular disease, diabetes, metabolic, thyroid, pulmonary, renal, hepatic, gastrointestinal, musculoskeletal disorders or medical or surgical events, such as bariatric surgery, heart surgery, or any joint or musculoskeletal surgeries occurring in the 6-months prior to enrollment, that may significantly influence study outcomes or prevent safe participation.
- Have uncontrolled hypertension or an abnormal electrocardiogram.
- Have a diagnosed mental disorder
- Inconsistently taking medications or taking medications that may influence study outcomes.
- Participating in more than 150 minutes per week of moderate exercise, more than 2 days per week of resistance training, or currently participating in high intensity interval training or participated in HIIT within the previous 12 weeks.
- Lost or gained greater than eight pounds within three months prior to the enrollment.
- Currently consuming a high protein diet (,1.6 g·kg-1·day-1 and \<25% of calories from protein).
- Currently consuming meal replacements or dietary supplements that may taurine, or beta-hydroxy beta-methylbutyrate) within eight weeks prior to the enrollment date.
- Reports any known sensitivity to the Essential Amino Acid treatment.
- Has participated in another clinical trial within four weeks prior to enrollment that in the opinion of the PI would influence the results.
- Has severely impaired hearing or speech or inability to speak English.
- Unwilling or unable to comply with the study protocol, including abstaining from, caffeine, tobacco, alcohol, and physical activity before testing days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Applied Physiology Laboratory, Fetzer Hall Room 25
Chapel Hill, North Carolina, 27599, United States
Related Publications (1)
Hirsch KR, Greenwalt CE, Cabre HE, Gould LM, Brewer GJ, Blue MNM, Ferrando AA, Huffman KM, Mayer-Davis EJ, Ryan ED, Smith-Ryan AE. Metabolic effects of high-intensity interval training and essential amino acids. Eur J Appl Physiol. 2021 Dec;121(12):3297-3311. doi: 10.1007/s00421-021-04792-4. Epub 2021 Aug 24.
PMID: 34427732DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Abbie Smith-Ryan, PhD
University of North Carolina, Chapel Hill
- PRINCIPAL INVESTIGATOR
Katie Hirsch, MA
University of North Carolina, Chapel Hill
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2019
First Posted
September 6, 2019
Study Start
March 1, 2019
Primary Completion
January 5, 2020
Study Completion
January 5, 2020
Last Updated
April 30, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Deidentified individual data that supports the results will be shared beginning 12 to 24 months following publication.
- Access Criteria
- An investigator who proposes to use the data must have approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and execute a data use/sharing agreement with UNC.
Deidentified individual data that supports the results will be shared beginning 12 to 24 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with University of North Carolina (UNC).